McKesson Corporation vs Revvity Inc — how do they compare? McKesson Corporation trades at $832.45 (market cap $97.35B), while Revvity Inc trades at $110.7 (market cap $11.87B). The key difference: McKesson Corporation is far larger — about 8.2× Revvity Inc's market cap, and McKesson Corporation pays the higher dividend (0.39%). Which is the better fit depends on your goals.
| MCK | RVTY | |
|---|---|---|
Market Cap | $97.35B | $11.87B |
Sector | Health | Technology |
52-Week High | $995.69 | $117.75 |
52-Week Low | $659.01 | $82.26 |
Enterprise Value | $101.98B | $14.36B |
Dividend Yield | 0.39% | 0.26% |
Trailing returns across standard periods
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →